Efficacy Study of the Use of Sequential DFP-DFO Versus DFP

NCT00733811 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia
Thalassemia Major

Interventions

DRUG: Deferiprone (DFP) and Deferoxamine (DFO)
DRUG: Deferiprone (DFP)

Sponsor

Azienda Ospedaliera V. Cervello